Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Allchem Lifescience

02 1Chemvisai Labs

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India
Not Confirmed
arrow
CPhI India
Not Confirmed
arrow

CAS Number : 20980-22-7

End Use API : Gepirone

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

02

CPhI India
Not Confirmed
arrow
CPhI India
Not Confirmed
arrow

CAS Number : 628-20-6

End Use API : Gepirone

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

03

CPhI India
Not Confirmed
arrow
CPhI India
Not Confirmed
arrow

CAS Number : 94021-22-4

End Use API : Gepirone

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

04

CPhI India
Not Confirmed
arrow
CPhI India
Not Confirmed
arrow

CAS Number : 1075-89-4

End Use API : Gepirone

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

05

CPhI India
Not Confirmed
arrow
CPhI India
Not Confirmed
arrow

CAS Number : 1123-40-6

End Use API : Gepirone

About The Company : Established in 2003 with small pilot plant and came in to commercial production in 2013 in the name of Allchem Laboratories, it is an independent privately owne...

blank

06

CPhI India
Not Confirmed
arrow
CPhI India
Not Confirmed
arrow

CAS Number : 1123-40-6

End Use API : Gepirone

About The Company : Chemvisai Labs is a dynamic pharmaceutical partner established with a clear vision: to become a leading and trusted force in the industry. We address critical u...

blank